SourceBio International PLC - Nottingham-based laboratory services provider - Says it has traded well since December 31 and is "pleased" with its progress to-date. Focusing on accelerating growth in its three core units: Healthcare Diagnostics, Genomics and Stability Storage.
In Healthcare Diagnostics, notes "exceptionally strong" market demand for its cellular pathology services, driven by elective surgeries coming back. Company focused on delivering the further capacity needed to meet the increasing demand for its Cellular Pathology testing services.
Reports a "healthy" start to the year for its Genomics business. In Stability Storage, company focused on growing its Stability Storage Services and Service & Validation business lines. Company has has ceased in-house manufacture of Stability Storage equipment due unprofitability.
Current stock price: 127.00 pence, up 1.6% in London
12-month change: down 23%
By Heather Rydings; heatherrydings@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.